LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Tubes Designed for Medium Sample Volumes

By LabMedica International staff writers
Posted on 03 Aug 2016
Print article
Image: The new 5.0 mL tube with screw cap (Photo courtesy of Eppendorf).
Image: The new 5.0 mL tube with screw cap (Photo courtesy of Eppendorf).
At the 2016 AACC annual meeting, Eppendorf (Hauppauge, NY, USA) will introduce a new 5 mL tube with a screw cap which fills the gap between existing tube formats and represents a novel option for working with medium–sized sample volumes.

The new 5.0 mL Tube will complement the application spectrum of sample processing in the medium volume range: in addition to sample processing, it can also be used for secure transport, long term storage at temperatures as low as -86 °C, and sample incubation at up to 100 °C. In addition to a secure seal, the grooved and multi-surface side contours of the newly designed screw cap ensure a slip-free grip. To accommodate individual laboratory protocols, it is available in Eppendorf Quality, PCR clean, Sterile, and Eppendorf Biopur purity grades.

Features include an ergonomic snap cap for single-handed operation; a screw cap with flattened end and grooved sides to provide optimal grip and user-friendly handling; a high-quality and transparent polypropylene construct free of plasticizers, biocides, or mold release agents; safety and stability for centrifugation up to 25,000 g; a conical shape compatible with accessories for conical 15 mL tubes; and caps made of proprietary LoBind material for maximum recovery of valuable samples. The new 5.0 mL Tube with screw cap will be presented at AACC 2016.

The American Association for Clinical Chemistry (AACC; Washington, DC, USA) is an international scientific/medical society of over 8,000 clinical laboratory professionals, physicians, research scientists and more. The AACC annual meeting, which will be held this year from July 31st to August 4th at the Pennsylvania Convention Center in Philadelphia (USA), features five days of educational sessions about scientific, clinical, technical and management challenges facing laboratory professionals, as well as the world’s largest Clinical Lab Expo.

Related Links:
Eppendorf
American Association for Clinical Chemistry
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Chlamydia Trachomatis Assay
Chlamydia Trachomatis IgG
New
Pipet Controller
Stripettor Pro

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.